Live Breaking News & Updates on Orporate bonds

Stay informed with the latest breaking news from Orporate bonds on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Orporate bonds and stay connected to the pulse of your community

Pension schemes prep facilities to 'repo' fund units

Schroders, State Street and Cardano plan new way to shore up pension portfolios against repeat of 2022 gilt crisis

Schroders , State-street-global-advisors , Tate-street-global-advisors , Nited-kingdom-uk- , Onds , Ollateral , Orporate-bonds , Unding , Iability-driven-investment-ldi- , Oans , Epo

EU banks' incremental risk charges soared in volatile H2

Charge for traded-bond default and downgrade risk hit ten-year high at BNP Paribas

France , French , European-union , Risk-quantum , Ing-group , Np-paribas , Eutsche-bank , Anske-bank , Ntesa-sanpaolo , Bva , Antander

Credit Likely to Stay Pricey for Months, Barclays Says

(Bloomberg) -- If history is any guide, investment-grade US corporate bonds can stay at current nosebleed valuations for months more. Most Read from BloombergTrumpism Is Emptying ChurchesIran’s Better, Stealthier Drones Are Remaking Global WarfareBlackstone Nears Buyout of Skin-Care Company L’OccitaneWhy India’s South Rejects Modi — And Why It MattersGermany to Order Ships, Armored Vehicles Worth Up to €7 BillionThat’s the conclusion of Barclays, which said that the present macro environment, an

Dallas , Texas , United-states , Ukraine , Gaza , Israel-general- , Israel , Daniel-sorid , Matt-eagan , Loomis-sayles , Dominique-toublan , Bloomberg-businessweek

RBI holds rates. Here's what debt mutual fund investors should do

After RBI's status quo, investors may continue to enhance duration across debt schemes with a view of softer rates and stable liquidity conditions going ahead

India , Baroda , Gujarat , Puneet-pal , Murthy-nagarajan , Parijat-agrawal , Saurav-ghosh , Sandeep-yadav , Achala-jethmalani , Union-mutual-fund , India-mutual-fund , Tata-mutual-fund

3 Myths About Investing in Bonds

Investing in bonds often gets a bad rap. Common misconceptions about bonds indicate that they’re boring, low-yield and ineffective for building long-term wealth.

Federal-reserve , Silver-directly-froma-bank , Bonds , Purchase-gold , Silver-directly-from , Ways-to-make-extra-money , That-actually-work , Bonds-only-offer-low , Louis-federal-reserve , Rising-interest-rates-mean-falling-bond , Cant-lose-money

Bond Markets Are Flooded With Deals to Fund M&A

(Bloomberg) -- Demand has grown so fervent for corporate bonds that investors are once again willing to finance big mergers and acquisitions — something they hesitated to do for much of last year.Most Read from BloombergBuffett Says ‘Eye-Popping’ Results Unlikely With Record CashInvestors Flee Tumbling EV Upstarts Once Hailed as ‘Next Tesla’Bezos, Nvidia Join OpenAI in Funding Humanoid Robot StartupLitquidity Salary Reports Help Bankers Measure Up Annual RaisesBody of Alexey Navalny Is Given to

Boston , Massachusetts , United-states , Hong-kong , Canada , Chongqing , China , Montreal , Quebec , America , Chinese , Raad-hossain

AbbVie Sells $15 Billion of Bonds to Buy ImmunoGen, Cerevel

(Bloomberg) -- Pharmaceutical giant AbbVie Inc. sold $15 billion of bonds in the US investment-grade market on Thursday to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., adding to a recent rush of buyout financings. Most Read from BloombergNvidia Rises Most in About Nine Months as AI Drives SalesStocks Rally as AI Craze Sweeps Across the World: Markets WrapT-Bills Without Tax Bills? This Fund Says It Cracked the CodeAT&T Says Mobile Network Restored as US St

United-states , America , Brian-smith , Caleb-mutua , Bloomberg-businessweek , Abbvie-inc , Caterpillar-financial-services-corp , Jpmorgan-chase-co , Exelon-corp , Citigroup-inc , Bonds-to-fund , Cerevel-therapeutics-holdings-inc